Latest round

Series A

Last raised

Dec 2022

Total raised

$20M

Investors

2

About D2M

Based in Suzhou, China, and established in 2020, D2M is a biopharmaceutical company that engages in the R&D of new drugs for tumors and autoimmune diseases. The company was co-established by Dr. Nan Bing and Dr. Dong Zhang. Dr. Nan Bing worked at Pfizer as a director of human genetics targeting. And Dr. Dong Zhang worked at Merck as a director of tumor immunity. D2M engages in the R&D of new drugs for tumors and autoimmune diseases. It self-developed genetics-centric and multi-omics integrated data targets discovery platforms, which discovered and verified new drug targets based on the genome-wide association study data of human diseases, integrated multi-omics data, and application of mendelian randomization simulation random trials.

Who invested in D2M

2 investors across 1 round

See all investors in D2M

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 26, 2022

    Amount

    $20M

    Investors

    Locked

Questions about D2M

Who invested in D2M?

D2M has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has D2M raised?

D2M has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did D2M last raise money?

D2M's most recent round on record is a Series A, in Dec 2022.

What does D2M do?

Based in Suzhou, China, and established in 2020, D2M is a biopharmaceutical company that engages in the R&D of new drugs for tumors and autoimmune diseases.

Where is D2M headquartered?

D2M is headquartered in Suzhou, China.

Which VCs invest in companies like D2M?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at D2M's stage. Their profiles are linked below.

Raising like D2M? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.